Infliximab does not interfere with insulin secretion, insulin resistance and production of GAD and islet cell antibodies in patients with Crohn's disease

作者: S. Gentile , G. Guarino , A. Bizzarro , A. De Bellis , R. Torella

DOI: 10.1046/J.1463-1326.2002.00210.X

关键词: EndocrinologyInsulin resistanceIsletCellImmunologyInsulin secretionMedicineInternal medicineCrohn's diseaseIn patientAntibodyInfliximab

摘要:

参考文章(5)
M Ohta, H Obayashi, K Takahashi, Y Kitagawa, K Nakano, S Matsuo, M Nishimura, N Itoh, K Ohta, Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus. Clinical Chemistry. ,vol. 42, pp. 1975- 1978 ,(1996) , 10.1093/CLINCHEM/42.12.1975
P. Fabris, A. Floreani, F.De Lazzari, C. Betterle, N.A. Greggio, R. Naccarato, M. Chiaramonte, Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. The Lancet. ,vol. 340, pp. 548- 548 ,(1992) , 10.1016/0140-6736(92)91744-S
C. A. Gysemans, D. Pavlovic, R. Bouillon, D. L. Eizirik, C. Mathieu, Dual role of interferon-gamma signalling pathway in sensitivity of pancreatic beta cells to immune destruction. Diabetologia. ,vol. 44, pp. 567- 574 ,(2001) , 10.1007/S001250051662